AI partner, Cancer, rebranding MASH… What happe
Post# of 155571
(Total Views: 532)
Posted On: 03/06/2024 9:12:56 PM
AI partner, Cancer, rebranding MASH…
What happened? Not sure I’m assuming these things are all still very much in the works.
I think this will be the year we start to see the big picture. That’s my hope. Not that I’m not excited about the trial. I just would like to see a something major like a trial in triple negative breast cancer with BP.
What happened? Not sure I’m assuming these things are all still very much in the works.
I think this will be the year we start to see the big picture. That’s my hope. Not that I’m not excited about the trial. I just would like to see a something major like a trial in triple negative breast cancer with BP.
(5)
(0)CytoDyn Inc (CYDY) Stock Research Links
Daniel Rizzo
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
HHS & SEC Whistleblower: HL-1412396
DOJ Investigation Report/ Whistleblower ID: 20250705-0001
NIH Case Reference: CS1137565
Founder & CEO of FireGate Bioscience
USPTO: Lead Inventor of the HIV Cure & AI Federal Oversight Program
⸻
Public Links
FireGate Bioscience: https://www.firegatebioscience.com
NotYourDrug.com: https://www.notyourdrug.com
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
HHS & SEC Whistleblower: HL-1412396
DOJ Investigation Report/ Whistleblower ID: 20250705-0001
NIH Case Reference: CS1137565
Founder & CEO of FireGate Bioscience
USPTO: Lead Inventor of the HIV Cure & AI Federal Oversight Program
⸻
Public Links
FireGate Bioscience: https://www.firegatebioscience.com
NotYourDrug.com: https://www.notyourdrug.com